NCT05058469

Tracheotomy With and Without Dual Antiplatelet Therapy

Evaluation of the Safety of Percutaneous Tracheotomies in Intensive Care Patients With and Without Antiplatelet Therapy and Comparison of Two Tracheotomy Techniques

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 300 (estimated)
• Sponsor: Asklepios Neurological Clinic Bad Salzhausen · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: —

Summary

Platelet-inhibiting drugs are often used after vascular interventions. Patients who require such therapies are often critically ill, are treated in intensive care units and often require long-term ventilation. For long-term ventilation a tracheotomy is necessary, which is usually performed as a percutaneous dilatative tracheotomy (PDT). As part of this intervention, there is (theoretically) an increased risk of bleeding/an increased rate of complications in patients with a antiplatelet therapy. In addition, there are various techniques for performing a PDT. The current study aims to investigate the frequency of bleeding/complications taking into account the technique used in PDT.

Conditions

• Tracheostomy Hemorrhage

Interventions

Type	Name	Description
DEVICE	Tracheotomy	Tracheotomy in patients +/- antiplatelet therapy

Timeline

• Start date: 2022-10-01
• Primary completion: 2024-12-01
• Completion: 2024-12-01
• First posted: 2021-09-27
• Last updated: 2024-07-31

Locations

1 site across 1 country: Germany